NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Pittsboro-based startup Propella Therapeutics is looking to China as a market for its new osteoarthritis treatment.
Durham-based Bioventus is buying fellow orthopedic device maker CartiHeal following FDA approval of its Agili-C cartilage repair implant.
If you’re an executive or director of one of North Carolina’s 790 life sciences companies, now’s the time to set aside May 4 on your corporate calendar to attend the NACD forum at NCBiotech in RTP "Leading from the Boardroom: Navigating the Life Science Boardroom."
Alamance Community College’s role in regional workforce development continues to grow, as it graduates over one-fourth of the state’s community college biotechnology talent.
Invitae, a California-based medical genetics company opening a lab and production facility in Morrisville, has commercially launched a new testing package for neurodevelopmental disorders in children.
Pathalys Pharma, a newly formed RTP biopharmaceutical company developing therapies for chronic kidney disease, has announced its executive leadership team, led by pharma veteran Neal Fowler.
Newly minted RTP cancer therapeutics developer Incyclix Bio has just received $30 million in Series B financing.
A team of North Carolina scientists, with early grant support from NCBiotech, has developed an implantable scaffold resembling a “mini marshmallow” that produces and releases CAR-T cells for attacking cancerous tumors.
Flush with cash, thanks in part to an early NCBiotech loan that helped spark a Series A and, now B round of funding, Duke spinout Lindy Biosciences is getting ready to scale.
Durham-based food technology startup Pairwise has launched a new brand, and a brand new product -- Conscious Foods and Conscious Greens.
Baebies Inc., a medical device and diagnostics company in Durham, has received regulatory clearance to commercialize a test for the COVID-19 virus in Europe.
NCBiotech has launched the NC BIONEER Venture Challenge to support life sciences startup commercialization, innovators, entrepreneurs, and companies across North Carolina.
City of Durham leaders have launched the Build Up Local Life Sciences (BULLS) initiative to help underrepresented young people connect with careers in the life sciences, including pharmaceutical manufacturing.
With impact investing on the rise, many of the nation’s top healthcare foundations are ramping up their ground game in the Triangle, tapping everything from talent to solutions, to tackle growing health disparities across the country.
Durham Tech and Wake Tech have launched RTP Bio, a workforce development collaboration that will unite the schools’ biotechnology, biomanufacturing and biopharmaceutical talent pipelines with the help of an ongoing funding pledge from major North Carolina newcomer Lilly.
scroll back to top of page